The world’s largest and most important HIV-related scientific meeting is less than a week away. AIDS 2012 will bring together over 25,000 delegates (including 2,500 registered media representatives) for a week of scientific discussions and dialogue between and among scientists,…
FDA approves first drug for reducing the risk of sexually acquired HIV infection
Cross-posted from FDA News Release
Today (July 16, 2012), the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may…




